BioStem Technologies (BSEM) vs Caribou Biosciences (CRBU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BioStem Technologies (BSEM) has outperformed Caribou Biosciences (CRBU) over the past year, losing 50.5% versus a loss of 82.0%. Over five years, BSEM leads with a +70.7% price change compared with -97.7% for CRBU. Caribou Biosciences is the larger company by market cap ($51.6 million vs $49.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BSEM | CRBU |
|---|---|---|
| Share price | $2.64 | $0.4812 |
| Market cap | $49.29M | $51.59M |
| 1-day change | +10.46% | -22.06% |
| YTD return | -37.27% | -69.74% |
| 1-year return | -50.52% | -82.04% |
| 5-year return | +70.71% | -97.69% |
| P/E ratio (TTM) | 3.00 | — |
| Forward P/E | 9.10 | — |
| EPS (TTM) | $0.88 | $-1.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.40 | $3.54 |
| 52-week low | $2.25 | $0.4503 |
| Distance from 52-week high | -68.57% | -86.39% |
| Average volume | 120.39K | 1.87M |
| Shares outstanding | 18.67M | 107.21M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BSEM has outperformed CRBU by 31.5 percentage points over the past year.
BSEM vs CRBU FAQ
Which is bigger, BioStem Technologies or Caribou Biosciences?
Caribou Biosciences (CRBU) is larger, with a market capitalization of $51.59M compared with $49.29M for BioStem Technologies (BSEM).
Which stock has performed better over the past year, BSEM or CRBU?
BSEM returned -50.52% over the past 12 months, compared with -82.04% for CRBU (price return, excluding dividends). Past performance does not predict future results.
Are BioStem Technologies and Caribou Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.